Novel studies suggest that Retatrutide , a dual stimulator targeting GLP-1 and gastric inhibitory peptide pathways , may represent a significant progress in physique control . Early clinical trials https://getretatrutideaustralia.com/blog/retatrutide-weight-loss-revolution-2026